Study #2023-0228
The Phoenix Trial: Phase II trial of cemiplimab for the non-operative management of localized dMMR colon cancer.
MD Anderson Study Status
Enrolling
Treatment Agent
Cemiplimab
Description
To learn if cemiplimab can help to control dMMR colon cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Colon Cancer
Study phase:
Phase II
Physician name:
Michael Overman
Department:
Gastrointestinal Medical Oncology
For general questions about clinical trials:
1-833-945-1429
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.